Last Update 21 Jan 26
Fair value Decreased 1.99%MOS: Strong Harvest And Buybacks Will Support Future Rebound
Analysts have trimmed their fair value estimate for Mosaic by about $0.66 per share. This reflects a blend of recent price target cuts tied to softer phosphate trends and demand deferrals, partly offset by a few upward revisions from firms that see some potential catalysts ahead.
Analyst Commentary
Recent research on Mosaic reflects a split view, with some firms trimming targets on near term headwinds and others seeing enough potential catalysts to justify modest target increases.
Bullish Takeaways
- Bullish analysts who raised price targets by about $2 point to potential catalysts that could support sentiment, even as they keep expectations measured.
- Some firms that maintain Buy or equivalent ratings despite lower targets see room for Mosaic to benefit if sector conditions stabilize and company execution improves.
- One global bank highlights areas for optimism, citing possible macro and industry catalysts. It still treats them as early and uncertain, which keeps growth expectations tempered but not absent.
- Another firm that nudged its target higher cites improved credibility. It suggests that consistent delivery on guidance could help narrow any valuation gap with peers over time.
Bearish Takeaways
- Bearish analysts cutting targets into the low to mid $30s generally point to softer phosphate trends, demand deferrals and a mixed setup in agriculture, all of which feed into more conservative valuation work.
- Some research highlights inconsistent phosphate performance and calls out a need for stronger execution before Mosaic can close any multiple gap with peers, which weighs on their growth and profitability assumptions.
- Several firms flag demand deferrals and a weaker near term demand season as risks for fertilizer pricing, which feeds directly into cautious revenue and margin forecasts.
- JPMorgan explicitly points to fragile U.S. phosphate demand, high phosphate prices versus historical levels, weaker farmer balance sheets and rising sulfur and ammonia costs. It also references lower projected EBITDA and earnings uncertainty when justifying its downgrade and lower target.
What's in the News
- Mosaic reported that from July 1, 2025 to September 30, 2025, it repurchased 0 shares for US$0 under its current buyback tranche, so activity paused during this period. (Company event filing)
- The company has completed the repurchase of 26,679,815 shares under the buyback announced on August 1, 2022, representing 8.05% of its shares for a total of US$1,069.46m. (Company event filing)
Valuation Changes
- Fair Value Estimate, trimmed slightly, moves from US$33.12 per share to about US$32.46 per share.
- Discount Rate, edges down, shifting from roughly 8.55% to about 8.53%.
- Revenue Growth, adjusted higher in the model, changing from roughly 2.32% to about 2.62%.
- Net Profit Margin, set a touch lower, moving from around 7.52% to about 7.38%.
- Future P/E, marked down slightly, going from about 14.06x to roughly 13.91x.
Key Takeaways
- Operational improvements and expansion into premium products are expected to lower costs, boost margins, and drive more consistent profitability.
- Favorable global supply constraints and increased agricultural demand position Mosaic for higher prices, supporting long-term revenue growth and earnings stability.
- Reliance on traditional fertilizers, global oversupply, regulatory pressure, and challenges in key markets threaten Mosaic's margins, revenue stability, and long-term profitability.
Catalysts
About Mosaic- Through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients in the United States, Brazil, China, Canada, Paraguay, Argentina, Japan, Colombia, India, Australia, Peru, Mexico, Honduras, the Dominican Republic, Thailand, Indonesia, and internationally.
- Investments in asset reliability, automation, and cost reductions (especially in Brazil and in U.S. phosphates) are expected to enable higher production volumes and lower unit costs going forward, directly enhancing net margins and earnings as asset downtime and extraordinary maintenance costs recede.
- Global fertilizer supply and demand dynamics remain favorable, with tight markets in both phosphate and potash due to limited new capacity, continued Chinese export restrictions, and record/near-record global shipments; this structural supply constraint, combined with robust farmer demand (driven by rising food needs and government support in key regions like India and Brazil), positions Mosaic to capture higher prices, lifting revenue and margins.
- Mosaic's expanded distribution footprint, particularly with the new Palmeirante facility in Brazil, positions the company to capitalize on long-term agricultural growth and arable land expansion in high-growth regions, supporting both top-line revenue growth and increased earnings stability.
- Entry into premium/value-added segments such as specialty fertilizers and biosciences (with Biosciences business expected to be EBITDA positive in Q4 and new product launches accelerating in 2026+) enables Mosaic to achieve higher average selling prices and expand gross margin over time.
- Industry trends toward consolidation and Mosaic's ability to flexibly redirect volumes to strong-demand markets support more stable pricing discipline, driving improved revenue quality and more consistent profitability across market cycles.
Mosaic Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming Mosaic's revenue will grow by 5.2% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 8.4% today to 6.5% in 3 years time.
- Analysts expect earnings to reach $851.3 million (and earnings per share of $3.03) by about September 2028, down from $940.0 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting $1.2 billion in earnings, and the most bearish expecting $326 million.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 19.0x on those 2028 earnings, up from 10.9x today. This future PE is lower than the current PE for the US Chemicals industry at 25.9x.
- Analysts expect the number of shares outstanding to decline by 0.08% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.2%, as per the Simply Wall St company report.
Mosaic Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Consolidation of revenues in phosphate and potash exposes Mosaic to commodity price cycles and potential long-term secular declines in demand driven by the rise of alternative crop inputs and precision agriculture, which could amplify revenue volatility and pressure future earnings.
- Persistent global overcapacity in potash and phosphate production-particularly with new supply from Russia, Belarus, and Morocco-threatens to keep downward pressure on prices and industry margins, potentially eroding Mosaic's net margins and diluting profitability.
- Increasing pressure to decarbonize agriculture and heightened scrutiny from international environmental regulators may lead to costly compliance requirements, carbon taxes, or tighter controls on fertilizer use; these would raise operational costs and compress net margins across Mosaic's core business.
- Brazil, a key growth market, is experiencing ongoing credit challenges, high interest rates, and a reduction in government farm input support, which could reduce farmer purchasing power, limit Mosaic's ability to expand its customer base, and increase bad debt risk, directly impacting revenues and earnings consistency.
- High capital intensity and a legacy asset base mean Mosaic faces significant ongoing maintenance, environmental remediation, and asset renewal costs; these could constrain free cash flow and impact overall profitability as environmental and safety standards become more demanding.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $40.456 for Mosaic based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $49.0, and the most bearish reporting a price target of just $33.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $13.1 billion, earnings will come to $851.3 million, and it would be trading on a PE ratio of 19.0x, assuming you use a discount rate of 8.2%.
- Given the current share price of $32.16, the analyst price target of $40.46 is 20.5% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Mosaic?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



